Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

25B-NBOH

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
25B-NBOH
Legal status
Legal status
Identifiers
  • 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC17H20BrNO3
Molar mass366.255 g·mol−1
3D model (JSmol)
  • BrC2=CC(=C(CCNCC1=C(C=CC=C1)O)C=C2OC)OC
  • InChI=1S/C17H20BrNO3/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-19-11-13-5-3-4-6-15(13)20/h3-6,9-10,19-20H,7-8,11H2,1-2H3
  • Key:RSUNJYKZRKIBNB-UHFFFAOYSA-N

25B-NBOH (2C-B-NBOH,NBOH-2C-B) is a derivative of the phenethylamine derived hallucinogen2C-B which has been sold as adesigner drug. It acts as a potentserotonin receptoragonist with similar affinity to the better-known compound25B-NBOMe at5-HT2A and5-HT2C receptors withpKis[clarification needed] values of 8.3 and 9.4, respectively.[2][3][4][5][6][7]

Legal status

[edit]

Sweden

[edit]

TheRiksdag added 25B-NBOH toNarcotic Drugs Punishments Act under Swedish Schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 26, 2016, published byMedical Products Agency (MPA) in regulationHSLF-FS 2015:35 listed as 25B-NBOH, and 2-([2-(4-bromo-2,5-dimetoxifenyl)etylamino]metyl)fenol.[8]

United Kingdom

[edit]

This substance is aClass A drug in the United Kingdom as a result of theN-benzylphenethylamine catch-all clause in theMisuse of Drugs Act 1971.[9]

References

[edit]
  1. ^Anvisa (2023-07-24)."RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-07-25).Archived from the original on 2023-08-27. Retrieved2023-08-27.
  2. ^Heim R (19 March 2004).Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur (Ph.D. thesis). Freie Universität Berlin. Archived fromthe original on 16 April 2012. Retrieved27 June 2015.
  3. ^Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (March 2014)."Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists".ACS Chemical Neuroscience.5 (3):243–9.doi:10.1021/cn400216u.PMC 3963123.PMID 24397362.
  4. ^Hansen M (2010-12-16).Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen.doi:10.13140/RG.2.2.33671.14245.
  5. ^Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, et al. (April 2011). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers".European Journal of Nuclear Medicine and Molecular Imaging.38 (4):681–93.doi:10.1007/s00259-010-1686-8.PMID 21174090.S2CID 12467684.
  6. ^Silva ME, Heim R, Strasser A, Elz S, Dove S (January 2011). "Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor".Journal of Computer-Aided Molecular Design.25 (1):51–66.Bibcode:2011JCAMD..25...51S.CiteSeerX 10.1.1.688.2670.doi:10.1007/s10822-010-9400-2.PMID 21088982.S2CID 3103050.
  7. ^Braden MR, Parrish JC, Naylor JC, Nichols DE (December 2006)."Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists".Molecular Pharmacology.70 (6):1956–64.doi:10.1124/mol.106.028720.PMID 17000863.S2CID 15840304.
  8. ^"Läkemedelsverkets föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotik" [The Swedish Medicines Agency's regulations on amendments to the Swedish Medicines Agency's regulations (LVFS 2011: 10) on lists of drugs](PDF). Läkemedelsverket. Archived fromthe original(PDF) on 2017-10-31. Retrieved2017-04-21.
  9. ^"The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014".UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=25B-NBOH&oldid=1322754894"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp